Jinhe Biotechnology's controlling shareholder, Jinhe Holdings, has completed a reduction in holdings, totaling a 3% share reduction
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, Jinhe Biotechnology announced that the share reduction plan of its controlling shareholder, Jinhe Holdings, has been completed. From August 11, 2025, to September 1, 2025, it reduced its holdings by a total of 22.5631 million shares through block trades and centralized bidding, accounting for 3% of the total share capital of the company after excluding repurchased shares
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments